EN HU
logo Tudóstér

Fenyvesi Ferenc

Fenyvesi Ferenc
University of Debrecen Faculty of Pharmacy
Molekuláris és Nanogyógyszerészeti Tanszék

Publication list

Tudóstér co-authors statistics filterable publication list
Uploaded publications:
119
Publications in DEA:
116
OA:
70
Date range:
2004-2024
2024
1.
Képes, Z., Péli-Szabó, J., Kálmán-Szabó, I., Sass, T., Esze, R., Opposits, G., Jószai, I., Szikra, D. P., Fenyvesi, F., Hajdu, I., Trencsényi, G.: 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: a Proof-of-concept Preclinical Study.
In Vivo. 38 (6), 2591-2600, 2024.
doi DEA Scopus
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Pharmacology
2.
Ciceu, A., Fenyvesi, F., Hermenean, A., Ardelean, S., Dumitra, S., Puticiu, M.: Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: molecular Mechanisms and Nanoparticulate Drug Delivery Systems.
Int. J. Mol. Sci. 25 (17), 1-58, (article identifier: 9346), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
3.
Herczeg, M., Demeter, F., Nagy, T., Rusznyák, Á., Hodek, J., Sipos, É., Lekli, I., Fenyvesi, F., Weber, J., Kéki, S., Borbás, A.: Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.
Int. J. Mol. Sci. 25 (1), 1-29, (article identifier: 677), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
4.
Hermenean, A., Dossi, E., Hamilton, A., Trotta, M. C., Russo, M., Lepre, C. C., Sajtos, C., Rusznyák, Á., Váradi, J., Bácskay, I., Budai, I., D'Amico,, M., Fenyvesi, F.: Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin-Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics.
Pharmaceuticals (Basel). 17 (1), 1-20, (article identifier: 107), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
5.
Balta, C., Herman, H., Ciceu, A., Lepre, C. C., Mladin, B., Rosu, M., Oatis, D., Russo, M., Peteu, V. E., Gherghiceanu, M., Fenyvesi, F., Cotoraci, C., Trotta, M. C., D'Amico,, M., Hermenean, A.: Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosis.
Biochem. Pharmacol. 229, 116474,, (article identifier: 116474), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Biochemistry
Q1 Pharmacology
6.
Takács, P., Kozma, B., Rátonyi, D., Kozma, B., Kiss-Szikszai, A., Fenyvesi, F., Sipos, A. G.: Development and Bioavailability Assessment of an Estriol-Containing Vaginal Hydrogel.
Gels. 10 (12), 1-13, (article identifier: 823), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Bioengineering
Q2 Biomaterials
Q1 Organic Chemistry
Q1 Polymers and Plastics
7.
Váradi, J., Oláh, B., Hosszú, D., Fenyvesi, F., Gálné Remenyik, J., Homoki, J., Nagy, B. J., Fejes, Z., Bácskay, I., Klusóczki, Á.: Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis.
Eur. J. Pharm. Sci. 200, 1-10, (article identifier: 106846), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmaceutical Science
8.
Ababneh, H. M., Balogh, E., Csiki, D. M., Lente, G., Fenyvesi, F., Tóth, A., Jeney, V.: High glucose promotes osteogenic differentiation of human lens epithelial cells through hypoxia-inducible factor (HIF) activation.
J. Cell. Physiol. 239 (5), 1-12, (article identifier: 31211), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Cell Biology
Q1 Clinical Biochemistry
Q1 Physiology
9.
Demeter, F., Peleskei, Z., Kútvölgyi, K., Rusznyák, Á., Fenyvesi, F., Kajtár, R., Sipos, É., Lekli, I., Molnár, P., Szöllősi, A. G., Lisztes, E., Tóth, I. B., Borbás, A., Herczeg, M.: Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.
Biomolecules. 14 (9), 1-24, (article identifier: 1052), 2024.
doi DEA
Journal metrics:
Q1 Biochemistry
Q2 Molecular Biology
10.
Ibrahim, Z., Fenyvesi, F.: The role of KRAS in Macropinocytosis and its implications of Multi-Drug Resistance in Cancer.
DRem. 1 (1), 39-49, 2024.
doi DEA
2023
11.
Gyöngyösi, A., Csáki, N., Pető, Á., Szőke, K., Fenyvesi, F., Bácskay, I., Lekli, I.: BGP-15 Protects against Doxorubicin-Induced Cell Toxicity via Enhanced Mitochondrial Function.
Int. J. Mol. Sci. 24 (6), 1-13, (article identifier: 5269), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
12.
Gutay-Tóth, Z., Gellén, G., Doan-Xuan, Q. M., Eliason, J. F., Vincze, J., Szente, L., Fenyvesi, F., Goda, K., Vecsernyés, M., Szabó, G., Bacsó, Z.: Cholesterol-Depletion-Induced Membrane Repair Carries a Raft Conformer of P-Glycoprotein to the Cell Surface, Indicating Enhanced Cholesterol Trafficking in MDR Cells, Which Makes Them Resistant to Cholesterol Modifications.
Int. J. Mol. Sci. 24 (15), 12335, (article identifier: 12335), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
13.
Trotta, M. C., Herman, H., Ciceu, A., Mladin, B., Rosu, M., Lepre, C. C., Russo, M., Bácskay, I., Fenyvesi, F., Marfella, R., Hermenean, A., Balta, C., D'Amico,, M.: Chrysin-based supramolecular cyclodextrin-calixarene drug delivery system: a novel approach for attenuating cardiac fibrosis in chronic diabetes.
Front. Pharmacol. 14, 1-17, (article identifier: 1332212), 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
14.
Klusóczki, Á., Oláh, B., Hosszú, D., Fenyvesi, F., Gálné Remenyik, J., Homoki, J., Gyöngyösi, A., Bácskay, I., Váradi, J.: Effectiveness of Anthocyanin-Rich Sour Cherry Extract on Gliadin-Induced Caco-2 Barrier Damage.
Nutrients. 15 (18), 1-16, (article identifier: 4022), 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Food Science
D1 Nutrition and Dietetics
15.
Demeter, F., Török, P., Kiss, A., Kovásznai-Oláh, R., Máthéné Szigeti, Z., Baksa, V., Kovács, F., Balla, N., Fenyvesi, F., Váradi, J., Borbás, A., Herczeg, M.: First Synthesis of DBU-Conjugated Cationic Carbohydrate Derivatives and Investigation of Their Antibacterial and Antifungal Activity.
Int. J. Mol. Sci. 24 (4), 1-20, (article identifier: 3550), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
16.
Rusznyák, Á., Réti-Nagy, K., Váradi, J., Bácskay, I., Vecsernyés, M., Fenyvesi, F.: Hidroxi-propil-béta-ciklodextrin celluláris internalizációjának és lizoszómákra gyakorolt hatásának vizsgálata.
egis. 2 (2), 57-64, 2023.
doi DEA
17.
Képes, Z., Hajdu, I., Fenyvesi, F., Trencsényi, G.: Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era.
Int. J. Pharm. 640, 1-12, (article identifier: 122978), 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmaceutical Science
18.
Péli-Szabó, J., Csige, K., Kálmán-Szabó, I., Arató, V. Z., Opposits, G., Jószai, I., Kertész, I., Képes, Z., Méhes, G., Fenyvesi, F., Hajdu, I., Trencsényi, G.: In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-[béta]-cyclodextrin (HPβCD) using positron emission tomography.
Int. J. Pharm. 630, 1-8, (article identifier: 122462), 2023.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmaceutical Science
2022
19.
Rusznyák, Á., Palicskó, M., Malanga, M., Fenyvesi, É., Szente, L., Váradi, J., Bácskay, I., Vecsernyés, M., Réti-Nagy, K., Vasvári, G., Haimhoffer, Á., Fenyvesi, F.: Cellular Effects of Cyclodextrins: studies on HeLa Cells.
Molecules. 27 (5), 1589, 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
20.
Pham Le Khanh, H., Nemes, D., Rusznyák, Á., Ujhelyi, Z., Fehér, P., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Comparative Investigation of Cellular Effects of Polyethylene Glycol (PEG) Derivates.
Polymers. 14, 1-15, (article identifier: 279), 2022.
DEA WoS Scopus
Journal metrics:
Q1 Chemistry (miscellaneous)
Q1 Polymers and Plastics
21.
Gálné Remenyik, J., Biró, A., Klusóczki, Á., Juhász, K. Z., Szendi-Szatmári, T., Kenesei, Á., Szőllősi, E., Vasvári, G., Stündl, L., Fenyvesi, F., Váradi, J., Markovics, A.: Comparison of the Modulating Effect of Anthocyanin-Rich Sour Cherry Extract on Occludin and ZO-1 on Caco-2 and HUVEC Cultures.
Int. J. Mol. Sci. 23 (16), 1-13, (article identifier: 9036), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
22.
Kovács, R. L., Erdélyi, L. J., Fenyvesi, F., Balla, N., Kovács, F., Vámosi, G., Klusóczki, Á., Gyöngyösi, A., Bácskay, I., Vecsernyés, M., Váradi, J.: Concentration-Dependent Antibacterial Activity of Chitosan on Lactobacillus plantarum.
Pharmaceutics. 15 (1), 1-11, (article identifier: 18), 2022.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmaceutical Science
23.
Veszelka, S., Mészáros, M., Porkoláb, G., Rusznyák, Á., Réti-Nagy, K., Deli, M. A., Vecsernyés, M., Bácskay, I., Váradi, J., Fenyvesi, F.: Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells.
Molecules. 27 (22), 1-15, (article identifier: 7738), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
24.
Trotta, M. C., Petrillo, F., Gesualdo, C., Rossi, S., Corte, A. D., Váradi, J., Fenyvesi, F., D'Amico,, M., Hermenean, A.: Effects of the Calix[4]arene Derivative Compound OTX008 on High Glucose-Stimulated ARPE-19 Cells: focus on Galectin-1/TGF-β/EMT Pathway.
Molecules. 27 (15), 1-15, (article identifier: 4785), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
25.
Józsa, L., Vasvári, G., Sinka, D. Z., Nemes, D., Ujhelyi, Z., Vecsernyés, M., Váradi, J., Fenyvesi, F., Lekli, I., Gyöngyösi, A., Bácskay, I., Fehér, P.: Enhanced Antioxidant and Anti-Inflammatory Effects of Self-Nano and Microemulsifying Drug Delivery Systems Containing Curcumin.
Molecules. 27 (19), 1-22, (article identifier: 6652), 2022.
doi DEA WoS Scopus
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.